NEW YORK (GenomeWeb News) — TriPath Imaging today said that its shareholders have approved Becton Dickinson’s $350-million bid to acquire the company.
 
The company said it expects the deal to close by tomorrow.
 
In September, BD said it would acquire 93.5 percent of TriPath’s shares for $350 million. TriPath said today that BD has agreed to pay $9.25 a share for the firm’s common stock, which is where the stock was trading this afternoon.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.